Capital Impact Advisors, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Capital Impact Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	SELL	$92.19 - $115.71 $144,922 - $181,896	-1,572 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$106.9 - $167.73 $2.57 Million - $4.03 Million	-24,010 Reduced 93.86%	1,572 $179,000
Q4 2020 Feb 12, 2021	SELL	$84.4 - $177.39 $2.11 Million - $4.43 Million	-25,000 Reduced 49.42%	25,582 $3.54 Million
Q3 2020 Nov 13, 2020	BUY	$72.98 - $90.0 $1.46 Million - $1.8 Million	20,000 Added 65.4%	50,582 $4.16 Million
Q2 2020 Aug 17, 2020	SELL	$46.91 - $78.22 $719,599 - $1.2 Million	-15,340 Reduced 33.4%	30,582 $2.39 Million
Q1 2020 May 15, 2020	BUY	$33.8 - $62.9 $60,468 - $112,528	1,789 Added 4.05%	45,922 $2.04 Million
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $338,640 - $502,860	7,968 Added 22.03%	44,133 $1.88 Million
Q2 2019 Jul 19, 2019	SELL	$54.93 - $74.36 $92,996 - $125,891	-1,693 Reduced 4.47%	36,165 $2.24 Million
Q4 2018 Mar 08, 2019	BUY	$38.89 - $77.3 $354,365 - $704,357	9,112 Added 31.7%	37,858 $1.59 Million
Q3 2018 Oct 19, 2018	BUY	$71.81 - $90.15 $120,066 - $150,730	1,672 Added 6.18%	28,746 $2.3 Million
Q2 2018 Jul 25, 2018	SELL	$48.54 - $85.31 $238,671 - $419,469	-4,917 Reduced 15.37%	27,074 $2.06 Million
Q1 2018 Apr 11, 2018	BUY	$44.33 - $58.52 $1.42 Million - $1.87 Million	31,991 New	31,991 $1.63 Million

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.